Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanobiotech Researcher Receives State Funds to Support Commercialization of diabetes treatment

Microcapsules with embedded gadolium-gold nanoparticles can be easily visualized with A (T1-weighted positive contrast MR imaging), B (T2-weighted negative contrast MR imaging). C (X-ray/CT imaging) or D (ultrasound imaging). (Credit: Dian Arifin/Bulte Lab)
Microcapsules with embedded gadolium-gold nanoparticles can be easily visualized with A (T1-weighted positive contrast MR imaging), B (T2-weighted negative contrast MR imaging). C (X-ray/CT imaging) or D (ultrasound imaging). (Credit: Dian Arifin/Bulte Lab)

Abstract:
On June 4, the state announced 12 winning research projects that will receive part of $3 million in nanobiotechnology research funding from the 2009 Maryland Nanobiotechnology Research and Industry Competition Grants. Jeff Bulte, an affiliated faculty member of the Institute for NanoBioTechnology and professor of Radiology in the School of Medicine, received a one-time $230,000 to commercialize a promising therapy for type 1 diabetes.

Nanobiotech Researcher Receives State Funds to Support Commercialization of diabetes treatment

Baltimore, MD | Posted on June 24th, 2009

Bulte and his postdoctoral fellow Dian Arifin are collaborating with the Baltimore-based company Surgivison Inc. on a project entitled Image-Guided Encapsulated Cell Therapy using Multimodal Nanoparticles. Bulte explains that the project aims to develop microcapsules that contain human islets, the insulin producing cluster of cells in the pancreas, which will be part of a cell therapy for type 1 diabetes. The microcapsules are engineered to protect the islets from attack by the immune system, which would normally treat them as foreign invaders. In addition, the transplanted islets microcapsules also have gadolinium-gold nanoparticles embedded in them so that they can be easily seen with non-invasive imaging techniques, such as magnetic resonance, X-ray, computerized tomography, or ultrasound.

"The gadolium-gold nanoparticles allow the encapsulated islets to be injected under imaging guidance. That way you can monitor how many microparticles actually make it to the target site and how many capsules rupture and are subsequently rejected by the immune system," says Bulte. "As part of our team, Surgivision Inc. is developing catheters and injection devices that can be used to deliver and detect our encapsulated islets in real-time."

According to a press release from the state Department of Business and Economic Development (DBED), this was Maryland's first nanobiotechnology research grants competition. DBED, through the Maryland Biotechnology Center, and Maryland Technology Development Corporation jointly administered the nanotechnology grant competition. 103 applications were received in response to the competition's solicitation with 43 finalists subject to technical reviews of their research proposals.

Said Gov. Martin O'Malley in the release, "These grants are an important part of our long-term strategy for growing Maryland's bioscience industry, creating jobs, and positioning Maryland as a national leader in bio and life sciences… (They) will provide critical funding to Maryland companies working to develop innovative life saving technologies for the treatment of cancer and diagnosis of infectious diseases."

####

About Johns Hopkins Institute for NanoBioTechnology
The Johns Hopkins Institute for NanoBioTechnology (INBT) at Johns Hopkins University brings together more than 175 researchers from the Bloomberg School of Public Health, Krieger School of Arts and Sciences, School of Medicine, Applied Physics Laboratory, and Whiting School of Engineering to create new knowledge and new technologies at the interface of nanoscience and medicine.

For more information, please click here

Contacts:
Johns Hopkins Institute for NanoBioTechnology
3400 North Charles Street
Baltimore, MD 21218


Phone: (410) 516-3423
Fax: (410) 516-2355

Copyright © Johns Hopkins Institute for NanoBioTechnology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Imaging electric charge propagating along microbial nanowires October 20th, 2014

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Physicists build reversible laser tractor beam October 20th, 2014

Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014

Nanomedicine

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

Tuning light to kill deep cancer tumors: Nanoparticles developed at UMass Medical School advance potential clinical application for photodynamic therapy October 15th, 2014

Announcements

Imaging electric charge propagating along microbial nanowires October 20th, 2014

Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014

Physicists build reversible laser tractor beam October 20th, 2014

Removal of Limitations of Composites at Superheat Temperatures October 20th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014

QD Vision Wins Prestigious Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency October 16th, 2014

Beyond LEDs: Brighter, new energy-saving flat panel lights based on carbon nanotubes - Planar light source using a phosphor screen with highly crystalline single-walled carbon nanotubes (SWCNTs) as field emitters demonstrates its potential for energy-efficient lighting device October 14th, 2014

Unique catalysts for hydrogen fuel cells synthesized in ordinary kitchen microwave oven October 14th, 2014

Nanobiotechnology

Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014

Scientists Map Key Moment in Assembly of DNA-Splitting Molecular Machine: Crucial steps and surprising structures revealed in the genesis of the enzyme that divides the DNA double helix during cell replication October 15th, 2014

DNA nano-foundries cast custom-shaped metal nanoparticles: DNA's programmable assembly is leveraged to form precise 3D nanomaterials for disease detection, environmental testing, electronics and beyond October 10th, 2014

Charged graphene gives DNA a stage to perform molecular gymnastics October 9th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE